Mark Howard Snyder - 12 Jun 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF LEGAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
12 Jun 2025
Net transactions value
-$147,858
Form type
4
Filing time
13 Jun 2025, 17:33:05 UTC
Previous filing
24 Feb 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 13 Jun 2025 0001902866

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +5,035 +18% $0.000000 33,524 12 Jun 2025 Direct
transaction HALO Common Stock Tax liability $147,858 -2,711 -8.1% $54.54 30,813 12 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -5,035 -25% $0.000000 15,102 12 Jun 2025 Common Stock 5,035 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,711 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.